Sherin M Elfeky

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Future medicinal chemistry

Antibiotics (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Archiv der Pharmazie

Mansoura University Faculty of Pharmacy

King Abdulaziz University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mansoura University Faculty of Pharmacy

Egypt

Lecturer :: pharmaceutical organic chemistry

Education History

King Abdulaziz University May 01 2019

Saudi Arabia

PHD :: Pharmaceutical Organic Chemistry

Mansoura University Faculty of Pharmacy

Egypt

MSC :: pharmaceutical organic chemistry

Publications

Samar A El-Kalyoubi, Samiha A El-Sebaey, A M Rashad, Hanan A Al-Ghulikah, Mostafa M Ghorab, Sherin M Elfeky
Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Wael Shehta, Fatimah Agili, Basant Farag, Shaker Youssif, Samar J Almehmadi, Sherin M Elfeky, Samar A El-Kalyoubi
Synthesis and in vitro study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity. Future medicinal chemistry 15 (8) (2023)
Wael Shehta, Fatimah Agili, Basant Farag, Shaker Youssif, Samar J Almehmadi, Sherin M Elfeky, Samar A El-Kalyoubi
Synthesis and in vitro study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity. Future medicinal chemistry (2023)
Aya A Mahfouz, Heba Shehta Said, Sherin M Elfeky, Mona I Shaaban
Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Wael Shehta, Fatimah Agili, Basant Farag, Shaker Youssif, Samar J Almehmadi, Sherin M Elfeky, Samar A El-Kalyoubi
Synthesis and in vitro study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity. Future medicinal chemistry 15 (8) (2023)
Aya A Mahfouz, Heba Shehta Said, Sherin M Elfeky, Mona I Shaaban
Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Sherin M Elfeky, Tariq R Sobahi, Magdy M Gineinah, Nesreen S Ahmed
Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors. Archiv der Pharmazie 353 (1) (2019)

Sherin M Elfeky.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sherin M Elfeky